## Abstract The __MDM2__ and __CDK4__ genes are the main targets of chromosome 12 amplification in well‐differentiated and dedifferentiated liposarcomas. Nevertheless, around 10% of these tumors do not amplify __CDK4__. To find substitutive alterations of __CDK4__ amplification, we analyzed a large
✦ LIBER ✦
Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma
✍ Scribed by Horvai, Andrew E; DeVries, Sandy; Roy, Ritu; O'Donnell, Richard J; Waldman, Frederic
- Book ID
- 109887747
- Publisher
- Nature Publishing Group
- Year
- 2009
- Tongue
- English
- Weight
- 694 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0893-3952
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The CDKN2A/CDKN2B/CDK4/CCND1 pathway is
✍
Caroline Louis-Brennetot; Jean-Michel Coindre; Céline Ferreira; Gaëlle Pérot; Ph
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 568 KB
High-resolution genomic mapping reveals
✍
Xiaoke Wang; Yan W. Asmann; Michele R. Erickson-Johnson; Jennifer L. Oliveira; H
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 612 KB
## Abstract Well‐differentiated liposarcoma (WDLS) is one of the most common malignant mesenchymal tumors and dedifferentiated liposarcoma (DDLS) is a malignant tumor consisting of both WDLS and a transformed nonlipogenic sarcomatous component. Cytogenetically, WDLS is characterized by the presence
HMGA2 is the partner of MDM2 in well-dif
✍
Antoine Italiano; Laurence Bianchini; Frédérique Keslair; Stéphanie Bonnafous; N
📂
Article
📅
2008
🏛
John Wiley and Sons
🌐
French
⚖ 426 KB